sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Ceftobiprole

Ceftobiprole

CAS No.:
209467-52-7
Catalog Number:
AG00BGEK
Molecular Formula:
C20H22N8O6S2
Molecular Weight:
534.5687
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
95%
1 week
United States
$682
- +
10mg
95%
1 week
United States
$1098
- +
25mg
95%
1 week
United States
$2140
- +
50mg
95%
1 week
United States
$3390
- +
100mg
95%
1 week
United States
$5335
- +
Product Description
Catalog Number:
AG00BGEK
Chemical Name:
Ceftobiprole
CAS Number:
209467-52-7
Molecular Formula:
C20H22N8O6S2
Molecular Weight:
534.5687
MDL Number:
MFCD09954116
IUPAC Name:
(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)-pyrrolidin-3-yl]pyrrolidin-3-ylidene]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
InChI:
InChI=1S/C20H22N8O6S2/c21-20-24-14(26-36-20)11(25-34)15(29)23-12-17(31)28-13(19(32)33)9(7-35-18(12)28)5-8-2-4-27(16(8)30)10-1-3-22-6-10/h5,10,12,18,22,34H,1-4,6-7H2,(H,23,29)(H,32,33)(H2,21,24,26)/b8-5+,25-11-/t10-,12-,18-/m1/s1
InChI Key:
VOAZJEPQLGBXGO-SDAWRPRTSA-N
SMILES:
O/N=C(/c1nsc(n1)N)\C(=O)N[C@@H]1C(=O)N2[C@@H]1SCC(=C2C(=O)O)/C=C/1\CCN(C1=O)[C@H]1CNCC1
EC Number:
606-675-3
UNII:
5T97333YZK
Properties
Complexity:
1100  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
2  
Exact Mass:
534.11g/mol
Formal Charge:
0
Heavy Atom Count:
36  
Hydrogen Bond Acceptor Count:
13  
Hydrogen Bond Donor Count:
5  
Isotope Atom Count:
0
Molecular Weight:
534.566g/mol
Monoisotopic Mass:
534.11g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
257A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-2.4  
Literature
Title Journal
Managing community acquired pneumonia in the elderly - the next generation of pharmacotherapy on the horizon. Expert opinion on pharmacotherapy 20170801
Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008). Antimicrobial agents and chemotherapy 20101101
Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06. The Journal of antimicrobial chemotherapy 20081101
Activity of ceftobiprole compared with those of other agents against Staphylococcus aureus strains with different resistotypes by time-kill analysis. Diagnostic microbiology and infectious disease 20080201
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria. Antimicrobial agents and chemotherapy 20080101
Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees. Diagnostic microbiology and infectious disease 20071201
Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. Antimicrobial agents and chemotherapy 20070701
Clinical profile of ceftobiprole, a novel beta-lactam antibiotic. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20070601
Properties